Efficacy News and Research

RSS
Biosimilars could drive down drug prices and lead to $38.4 billion savings

Biosimilars could drive down drug prices and lead to $38.4 billion savings

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

JPND announces call for multinational research on understanding the mechanisms of non-pharmacological interventions

JPND announces call for multinational research on understanding the mechanisms of non-pharmacological interventions

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

Efficacy of surgical masks and N95 respirators in lowering SARS-CoV-2 transmission

Efficacy of surgical masks and N95 respirators in lowering SARS-CoV-2 transmission

Mathematical modeling the vaccination of children against SARS-CoV-2

Mathematical modeling the vaccination of children against SARS-CoV-2

Rapid antigen tests exhibit high accuracy for COVID-19 screening in children

Rapid antigen tests exhibit high accuracy for COVID-19 screening in children

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 omicron variant predicted to cause fewer deaths in Florida

SARS-CoV-2 omicron variant predicted to cause fewer deaths in Florida

Researchers discover a potential depression biomarker and why it affects women and men differently

Researchers discover a potential depression biomarker and why it affects women and men differently

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 shown to spread through cell-to-cell transmission

Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

SARS-CoV-2 Delta sublineage AY.4.2 shows no increase in cell entry or antibody evasion

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

History of SARS-CoV-2 infection affects longitudinal responses to BNT162b2 vaccine

History of SARS-CoV-2 infection affects longitudinal responses to BNT162b2 vaccine

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Bolstering current therapeutic antibody treatments to help fight Omicron infections

Bolstering current therapeutic antibody treatments to help fight Omicron infections

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Slight pH adjustment may turn a metabolic inhibiting drug into promising COVID-19 treatment

Slight pH adjustment may turn a metabolic inhibiting drug into promising COVID-19 treatment

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.